High-Throughput Mutation Profiling in Intraductal Papillary Mucinous Neoplasm (IPMN)
- 223 Downloads
Specific mutations leading to the development of various histological grades of intraductal papillary mucinous neoplasm (IPMN) have been partially characterized.
Analysis of 323 oncogenic mutations in 22 tumor-related genes was conducted, using a chip-based matrix-assisted laser desorption time-of-flight mass spectrometer of DNA extracted from microdissected cells of low-grade (n = 14), borderline (n = 6), and invasive IPMN (n = 7). Additional assays were performed on the DNA extracted from dyplastic cells found in the background of the adenocarcinoma.
We identified 9 K-ras mutations (low grade, 2/14; borderline, 1/6; invasive, 6/7), 3 p53 mutations (low grade, 1/14; invasive 2/7), and 2 PIK3CA mutations (low grade, 1/14; invasive, 1/7). K-ras, p53, and PIK3CA mutations present in the invasive cancer were absent in the adjacent precursor cells in 50% of the cases. In one patient, K-ras mutation was present in the precursor lesion and absent in the adjacent invasive lesion.
Of the 22 screened tumor-related genes, only K-ras, p53, and PIK3CA mutations were found in IPMN. K-ras mutations are more prevalent in invasive than premalignant IPMN. The variable coexistence of mutations in the invasive cancer and in the adjacent precursor cells may point to the heterogeneous nature of this tumor.
KeywordsIPMN Mutations High throughput
This paper was supported by a grant from the Israeli Cancer Institute.
- 1.Ohhashi K, Murakami Y, Maruyama M, et al. Four cases of “mucin producing” cancer of the pancreas on specific findings of the papilla Vater. Prog Dig Endosc 1982;20:348–51.Google Scholar
- 2.Kloppel G, Solcia E, Longnecker DS et al. Histological typing of tumors of the exocrine pancreas. In: World Health Organization international classification of tumors, 2nd ed. Berlin: Springer 1996:11–20.Google Scholar
- 25.Satoh K, Sawai T, Shimosegawa T, et al. The point mutation of c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and in intraductal mucin hypersecreting neoplasm of the pancreas. Int J Pancreat 1993;14:135–41.Google Scholar
- 31.Gallmeier E, Calhoun E, Kern SE. No mutations in PIK3CA identified in pancreatic carcinoma. NOGO 2004;8:2.Google Scholar